House Bill 1675

Source

Section 1

This section modifies existing section 18.64.257. Here is the modified chapter for context.

This chapter shall not prevent a medicare-approved dialysis center or facility operating a medicare-approved home dialysis program**, or a manufacturer of commercially available dialysate and dialysis devices used by home dialysis patients, or a manufacturer's agent acting on behalf of such manufacturer,** from selling, delivering, possessing, or dispensing directly to its dialysis patients, if prescribed by a physician licensed under chapter 18.57 or 18.71 RCW, dialysis devices and those legend drugs**, in case or full shelf lots,** determined by the commission pursuant to rule.

Section 2

This section modifies existing section 69.41.032. Here is the modified chapter for context.

This chapter shall not prevent a medicare-approved dialysis center or facility operating a medicare-approved home dialysis program**, or a manufacturer of commercially available dialysate used by home dialysis patients, or a manufacturer's agent acting on behalf of such manufacturer,** from selling, delivering, possessing, or dispensing directly to its dialysis patients, in case or full shelf lots, if prescribed by a physician licensed under chapter 18.57 or 18.71 RCW, those legend drugs determined by the commission pursuant to rule.


Created by @tannewt. Contribute on GitHub.